SCHEMBL2912642

SCHEMBL2912642

COC(c1ccccc1)C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2ccc(F)cc2N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
EPHX1 P07099 2/20 0.38
RAB9A P51151 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
METAP2 P50579 2/20 0.37
METAP1 P53582 1/20 0.37
CCR1 P32246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910028 0.92 SMN1; SMN2 (0.45) SMN1; SMN2TSHRMEN1KMT2AEPHX1
SCHEMBL2915018 0.86 SMN1; SMN2 (0.41) SMN1; SMN2TSHRMEN1KMT2AEPHX1
SCHEMBL2914472 0.83 MEN1 (0.36) SMN1; SMN2TSHRMEN1KMT2ACNR1
SCHEMBL2307838 0.81 NR1H4 (0.41) SMN1; SMN2TSHRRAB9ACYP3A4CYP2C19
SCHEMBL2913162 0.80 KMT2A (0.42) SMN1; SMN2TSHRMEN1KMT2ARAB9A
SCHEMBL2307306 0.78 NR1H4 (0.41) SMN1; SMN2TSHRMEN1KMT2ACYP3A4
SCHEMBL2306822 0.78 NR1H4 (0.41) SMN1; SMN2TSHRMEN1KMT2ACYP3A4
SCHEMBL2913502 0.78 YAP1 (0.44) SMN1; SMN2TSHRMEN1KMT2ARAB9A
SCHEMBL2913040 0.77 TSHR (0.44) SMN1; SMN2TSHRMEN1KMT2AEPHX1
SCHEMBL2912405 0.77 ALDH1A1 (0.40) SMN1; SMN2TSHRCNR1CNR2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed